Clinical trial
Pyridostigmine for the Treatment of Constipation in Parkinson Disease
NCT05603715 is registered in ClinicalTrials.gov with University of Vermont Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pyridostigmine for the Treatment of Constipation in Parkinson Disease
- Lead sponsor
- University of Vermont Medical Center
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- August 10, 2022
- Completion date
- December 31, 2026
- Enrollment
- 16 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.